1-H-QUINAZOLINE-2, 4-DIONES FOR USE IN THE TREATMENT OF NEURONAL CEROID LIPOFUSCINOSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120122903A1
SERIAL NO

13384280

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns the use of competitive AMPA receptor antagonists for the treatment, prevention or delay of progression of neuronal ceroid lipofuscinosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGLICHTSTRASSE 35 4056 BASEL 4056

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kalkman, Hans O Basel, CH 18 17
Mattes, Henri Bazel, FR 19 104

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation